Connect with our mission to advance T1D care
Screening involves a blood test covered by most patients’ insurance
A diabetes mellitus antibody panel examines blood for the presence of autoantibody proteins. These proteins indicate the autoimmune process in the pancreas has begun. This test is available through most diagnostic labs in the US.1,2
A community tied together
Support systems are available for families and patients with T1D. There is a network of advocates, healthcare providers, and educational groups ready to get involved today.
JDRF, the leading global funder of T1D research, has launched a groundbreaking screening initiative for T1D: T1Detect.VISIT NOW
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of T1D research.VISIT NOW
Taking Control of Your Diabetes (TCOYD) is an educational advocacy group for patients and the larger T1D community.VISIT NOW
Beyond Type 1
Beyond Type 1 is a nonprofit focusing on advocacy, education, and the path to a cure for T1D.VISIT NOW
Access more information about diabetes and which laboratory testing services are available through Quest Diagnostics™.VISIT NOW
Access the Diabetes Autoimmune Profile page for testing information and ordering instructions.VISIT NOW
Overview of the Pathophysiology and Disease Progression of Type 1 Diabetes (T1D)
Downloadable presentation that provides an overview of the incidence, burden, autoimmune pathophysiology and disease progression of T1D, and illustrates the importance of proactive screening and preserving beta-cell function.DOWNLOAD SLIDES
1. Ziegler A-G, Kick K, Bonifacio E, et al; for Fr1da Study Group. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA. 2020;323(4):339-351.
2. Insel RA, Dunne JL, Ziegler A-G. General population screening for type 1 diabetes: has its time come? Curr Opin Endocrinol Diabetes Obes. 2015;22(4):270-276.